LGVN Stock Analysis: Buy, Sell, or Hold?

LGVN - Longeveron Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.56
-0.02 (-3.47%) ▼
HOLD
MODERATE Confidence
Protect Your LGVN Gains
Last Updated: January 30, 2026
Earnings: Feb 27, 2026 26d

Get Alerted When LGVN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: LGVN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: LGVN is currently trading at $0.56, which is considered extended relative to its 30-day fair value range of $0.53 to $0.59.

Technical Outlook: Technically, LGVN is in a strong downtrend. Immediate support is located at $0.53, while resistance sits at $0.65. Short-term momentum is weak, with the stock down 3.5% recently.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.86 (+1083.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $0.53 - $0.59
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 45.8%

Protect Your Profits

Holding LGVN? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.5%)
  • BULLISH: Trading 1083.6% below Wall St target ($6.86)

Fair Price Analysis

30-Day Fair Range $0.53 - $0.59
Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $0.53
Resistance Level $0.65
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) -0.67
Wall Street Target $6.86 (+1083.6%)
Revenue Growth (YoY) -82.3%
Last updated: January 31, 2026 3:56 AM ET
Data refreshes hourly during market hours. Next update: 4:56 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$91 59 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$33 60 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$117 59 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$141 59 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$30 56 HOLD

Advanced LGVN Option Strategies

Professional options setups generated by AI based on today's LGVN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for LGVN

LGVN Technical Chart LGVN Price Prediction LGVN Earnings Date LGVN Investment Advisor LGVN Fair Price Analyzer LGVN Options Advisor LGVN Options Chain LGVN Options Analysis LGVN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals